Global Amyotrophic Lateral Sclerosis (ALS) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 316123
  • calendar_today Published On: Jul, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Amyotrophic Lateral Sclerosis (ALS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Amyotrophic Lateral Sclerosis (ALS) market size is estimated to be worth US$ 423.7 million in 2021 and is forecast to a readjusted size of USD 1203 million by 2028 with a CAGR of 16.1% during review period. Hospital accounting for % of the Amyotrophic Lateral Sclerosis (ALS) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Riluzole segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Amyotrophic Lateral Sclerosis (ALS) include Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, and Glemark Generics, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Amyotrophic Lateral Sclerosis (ALS) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Riluzole

Edaravone (Radicava)

Other

Market segment by Application can be divided into

Hospital

Drugs Store

Other

The key market players for global Amyotrophic Lateral Sclerosis (ALS) market are listed below:

Mitsubishi Tanabe Pharma

Sanofi

Mylan Pharma

Apotex

Glemark Generics

Covis Pharma

Sun Pharma

Lunan Pharma

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Amyotrophic Lateral Sclerosis (ALS) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Amyotrophic Lateral Sclerosis (ALS), with price, sales, revenue and global market share of Amyotrophic Lateral Sclerosis (ALS) from 2019 to 2022.

Chapter 3, the Amyotrophic Lateral Sclerosis (ALS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Amyotrophic Lateral Sclerosis (ALS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Amyotrophic Lateral Sclerosis (ALS) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Amyotrophic Lateral Sclerosis (ALS).

Chapter 13, 14, and 15, to describe Amyotrophic Lateral Sclerosis (ALS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Amyotrophic Lateral Sclerosis (ALS) Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Riluzole

1.2.3 Edaravone (Radicava)

1.2.4 Other

1.3 Market Analysis by Application

1.3.1 Overview: Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital

1.3.3 Drugs Store

1.3.4 Other

1.4 Global Amyotrophic Lateral Sclerosis (ALS) Market Size & Forecast

1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume (2017-2028)

1.4.3 Global Amyotrophic Lateral Sclerosis (ALS) Price (2017-2028)

1.5 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity Analysis

1.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Total Production Capacity (2017-2028)

1.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Amyotrophic Lateral Sclerosis (ALS) Market Drivers

1.6.2 Amyotrophic Lateral Sclerosis (ALS) Market Restraints

1.6.3 Amyotrophic Lateral Sclerosis (ALS) Trends Analysis

2 Manufacturers Profiles

2.1 Mitsubishi Tanabe Pharma

2.1.1 Mitsubishi Tanabe Pharma Details

2.1.2 Mitsubishi Tanabe Pharma Major Business

2.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services

2.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Sanofi

2.2.1 Sanofi Details

2.2.2 Sanofi Major Business

2.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Product and Services

2.2.4 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Mylan Pharma

2.3.1 Mylan Pharma Details

2.3.2 Mylan Pharma Major Business

2.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services

2.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Apotex

2.4.1 Apotex Details

2.4.2 Apotex Major Business

2.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Product and Services

2.4.4 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Glemark Generics

2.5.1 Glemark Generics Details

2.5.2 Glemark Generics Major Business

2.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product and Services

2.5.4 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Covis Pharma

2.6.1 Covis Pharma Details

2.6.2 Covis Pharma Major Business

2.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services

2.6.4 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Sun Pharma

2.7.1 Sun Pharma Details

2.7.2 Sun Pharma Major Business

2.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services

2.7.4 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 Lunan Pharma

2.8.1 Lunan Pharma Details

2.8.2 Lunan Pharma Major Business

2.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services

2.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Amyotrophic Lateral Sclerosis (ALS) Breakdown Data by Manufacturer

3.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Amyotrophic Lateral Sclerosis (ALS)

3.4 Market Concentration Rate

3.4.1 Top 3 Amyotrophic Lateral Sclerosis (ALS) Manufacturer Market Share in 2021

3.4.2 Top 6 Amyotrophic Lateral Sclerosis (ALS) Manufacturer Market Share in 2021

3.5 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Amyotrophic Lateral Sclerosis (ALS) Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Region

4.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Region (2017-2028)

4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2028)

4.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028)

4.3 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028)

4.4 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028)

4.5 South America Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028)

4.6 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Type (2017-2028)

5.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2028)

5.3 Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Application (2017-2028)

6.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2028)

6.3 Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)

7.2 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)

7.3 North America Amyotrophic Lateral Sclerosis (ALS) Market Size by Country

7.3.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028)

7.3.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)

8.2 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)

8.3 Europe Amyotrophic Lateral Sclerosis (ALS) Market Size by Country

8.3.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028)

8.3.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)

9.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)

9.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Market Size by Region

9.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)

10.2 South America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)

10.3 South America Amyotrophic Lateral Sclerosis (ALS) Market Size by Country

10.3.1 South America Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028)

10.3.2 South America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)

11.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)

11.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Market Size by Country

11.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Amyotrophic Lateral Sclerosis (ALS) and Key Manufacturers

12.2 Manufacturing Costs Percentage of Amyotrophic Lateral Sclerosis (ALS)

12.3 Amyotrophic Lateral Sclerosis (ALS) Production Process

12.4 Amyotrophic Lateral Sclerosis (ALS) Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Amyotrophic Lateral Sclerosis (ALS) Typical Distributors

13.3 Amyotrophic Lateral Sclerosis (ALS) Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors

Table 4. Mitsubishi Tanabe Pharma Major Business

Table 5. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services

Table 6. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Sanofi Basic Information, Manufacturing Base and Competitors

Table 8. Sanofi Major Business

Table 9. Sanofi Amyotrophic Lateral Sclerosis (ALS) Product and Services

Table 10. Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Mylan Pharma Basic Information, Manufacturing Base and Competitors

Table 12. Mylan Pharma Major Business

Table 13. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services

Table 14. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Apotex Basic Information, Manufacturing Base and Competitors

Table 16. Apotex Major Business

Table 17. Apotex Amyotrophic Lateral Sclerosis (ALS) Product and Services

Table 18. Apotex Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Glemark Generics Basic Information, Manufacturing Base and Competitors

Table 20. Glemark Generics Major Business

Table 21. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product and Services

Table 22. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Covis Pharma Basic Information, Manufacturing Base and Competitors

Table 24. Covis Pharma Major Business

Table 25. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services

Table 26. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Sun Pharma Basic Information, Manufacturing Base and Competitors

Table 28. Sun Pharma Major Business

Table 29. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services

Table 30. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Lunan Pharma Basic Information, Manufacturing Base and Competitors

Table 32. Lunan Pharma Major Business

Table 33. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services

Table 34. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)

Table 36. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 37. Market Position of Manufacturers in Amyotrophic Lateral Sclerosis (ALS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 38. Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Company, (K MT): 2020 VS 2021

Table 39. Head Office and Amyotrophic Lateral Sclerosis (ALS) Production Site of Key Manufacturer

Table 40. Amyotrophic Lateral Sclerosis (ALS) New Entrant and Capacity Expansion Plans

Table 41. Amyotrophic Lateral Sclerosis (ALS) Mergers & Acquisitions in the Past Five Years

Table 42. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022) & (K MT)

Table 43. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2023-2028) & (K MT)

Table 44. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022) & (USD Million)

Table 45. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2023-2028) & (USD Million)

Table 46. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 47. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)

Table 48. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2022) & (USD Million)

Table 49. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2023-2028) & (USD Million)

Table 50. Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2017-2022) & (USD/MT)

Table 51. Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2023-2028) & (USD/MT)

Table 52. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 53. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)

Table 54. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2022) & (USD Million)

Table 55. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2023-2028) & (USD Million)

Table 56. Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2017-2022) & (USD/MT)

Table 57. Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2023-2028) & (USD/MT)

Table 58. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)

Table 59. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2023-2028) & (K MT)

Table 60. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & (USD Million)

Table 61. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2023-2028) & (USD Million)

Table 62. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 63. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)

Table 64. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 65. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)

Table 66. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)

Table 67. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2023-2028) & (K MT)

Table 68. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & (USD Million)

Table 69. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2023-2028) & (USD Million)

Table 70. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 71. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)

Table 72. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 73. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)

Table 74. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022) & (K MT)

Table 75. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2023-2028) & (K MT)

Table 76. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022) & (USD Million)

Table 77. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2023-2028) & (USD Million)

Table 78. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 79. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)

Table 80. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 81. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)

Table 82. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)

Table 83. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2023-2028) & (K MT)

Table 84. South America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & (USD Million)

Table 85. South America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2023-2028) & (USD Million)

Table 86. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 87. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)

Table 88. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 89. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)

Table 90. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022) & (K MT)

Table 91. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2023-2028) & (K MT)

Table 92. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022) & (USD Million)

Table 93. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2023-2028) & (USD Million)

Table 94. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 95. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)

Table 96. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 97. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)

Table 98. Amyotrophic Lateral Sclerosis (ALS) Raw Material

Table 99. Key Manufacturers of Amyotrophic Lateral Sclerosis (ALS) Raw Materials

Table 100. Direct Channel Pros & Cons

Table 101. Indirect Channel Pros & Cons

Table 102. Amyotrophic Lateral Sclerosis (ALS) Typical Distributors

Table 103. Amyotrophic Lateral Sclerosis (ALS) Typical Customers

List of Figures

Figure 1. Amyotrophic Lateral Sclerosis (ALS) Picture

Figure 2. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type in 2021

Figure 3. Riluzole

Figure 4. Edaravone (Radicava)

Figure 5. Other

Figure 6. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application in 2021

Figure 7. Hospital

Figure 8. Drugs Store

Figure 9. Other

Figure 10. Global Amyotrophic Lateral Sclerosis (ALS) Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028

Figure 11. Global Amyotrophic Lateral Sclerosis (ALS) Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Sales (2017-2028) & (K MT)

Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Price (2017-2028) & (USD/MT)

Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity (2017-2028) & (K MT)

Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Geographic Region: 2022 VS 2028

Figure 16. Amyotrophic Lateral Sclerosis (ALS) Market Drivers

Figure 17. Amyotrophic Lateral Sclerosis (ALS) Market Restraints

Figure 18. Amyotrophic Lateral Sclerosis (ALS) Market Trends

Figure 19. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Manufacturer in 2021

Figure 20. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Manufacturer in 2021

Figure 21. Amyotrophic Lateral Sclerosis (ALS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 22. Top 3 Amyotrophic Lateral Sclerosis (ALS) Manufacturer (Revenue) Market Share in 2021

Figure 23. Top 6 Amyotrophic Lateral Sclerosis (ALS) Manufacturer (Revenue) Market Share in 2021

Figure 24. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2028)

Figure 25. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2017-2028)

Figure 26. North America Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (USD Million)

Figure 27. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (USD Million)

Figure 28. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (USD Million)

Figure 29. South America Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (USD Million)

Figure 30. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (USD Million)

Figure 31. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)

Figure 32. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2028)

Figure 33. Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2017-2028) & (USD/MT)

Figure 34. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)

Figure 35. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2017-2028)

Figure 36. Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2017-2028) & (USD/MT)

Figure 37. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)

Figure 38. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)

Figure 39. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2017-2028)

Figure 40. North America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2017-2028)

Figure 41. United States Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Canada Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Mexico Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)

Figure 45. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)

Figure 46. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2017-2028)

Figure 47. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2017-2028)

Figure 48. Germany Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. France Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. United Kingdom Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Russia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Italy Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2028)

Figure 54. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)

Figure 55. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2028)

Figure 56. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2017-2028)

Figure 57. China Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Korea Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)

Figure 64. South America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)

Figure 65. South America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2017-2028)

Figure 66. South America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)

Figure 70. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)

Figure 71. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2028)

Figure 72. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2017-2028)

Figure 73. Turkey Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Egypt Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South Africa Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Manufacturing Cost Structure Analysis of Amyotrophic Lateral Sclerosis (ALS) in 2021

Figure 78. Manufacturing Process Analysis of Amyotrophic Lateral Sclerosis (ALS)

Figure 79. Amyotrophic Lateral Sclerosis (ALS) Industrial Chain

Figure 80. Sales Channel: Direct Channel vs Indirect Channel

Figure 81. Methodology

Figure 82. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz